Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
作者： Tracey J. Brown , Gary R. Brownlee
DOI:
关键词:
摘要: The present invention relates generally to treatment and prophylactic protocols for cellular diseases or disorders, such as disorders associated with abnormal proliferation. More particularly, the provides compositions comprising therapeutic antibodies hyaluronan their use in prophylaxis of disorders.
lens.org参考文章(93)
Endre A. Balazs, Ultrapure hyaluronic acid and the use thereof ,(1977)
Luke R. Bucci, WILL THE REAL HYALURONAN PLEASE STAND UP ,(2006)
Felix Theeuwes, Microporous-semipermeable laminated osmotic system ,(1979)
Fortunato J. Micale, Pigment encapsulated latex aqueous colorant dispersions ,(1986)
Tomas Björkman, B Bergström, B Glimelius, G Westerberg, B Langström, J Bergh, Stefan Gustafson, Tarja Wikström, T Lind, K Lidholt, T.C. Laurent, Peter McCourt, M de la Torre, Karin Lilja, J-E Westlin, Ulf Lindahl, H Hafberg, K Fuxe, B Tinner, Nina Forsberg, Studies on receptors for hyaluronan and the turnover of radioactively-labelled hyaluronan in mice and rats ,vol. 36, pp. 5- 7 ,(1995)
Felix Theeuwes, Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina ,(1977)
David Renier, Lanfranco Callegaro, Biomaterials comprising N-sulphated hyaluronic acid compounds or derivatives thereof ,(1998)
Agnese Magnani, Gloria Cialdi, Sulfated hyaluronic acid and esters thereof ,(1999)
David L. Urdal, Helmut M. Sassenfeld, Nonglycosylated human interleukin-3 analog proteins ,(1990)
Leonard Buckbinder, Nikolai A. Kley, Bernd R. Seizinger, Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors ,(1996)